LIN vs TCBIO · P/E 34, rev $18.07B vs P/E 5.2, $3.31B cap
Linde plc Ordinary Shares (LIN) versus Texas Capital Bancshares, Inc. (TCBIO) — a side-by-side from cached financials, not a winner call.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
Texas Capital Bancshares, Inc. (TCBIO) is a banks - regional company listed on US.
Latest reported LIN revenue for 2026-06-30 was $18.07B. Net income was $3.79B. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
TCBIO does not have a complete income-statement cache yet.
LIN currently screens at market cap $223.87B and trailing P/E 34.5. TCBIO currently screens at market cap $3.31B and trailing P/E 5.2.
Not investment advice. Open the LIN and TCBIO stock pages for the full models.
Not investment advice.